Leerink Partnrs Has Positive Forecast for ASND Q1 Earnings
Ascendis Pharma A/S (NASDAQ:ASND – Free Report) – Investment analysts at Leerink Partnrs lifted their Q1 2025 earnings per share (EPS) estimates for shares of Ascendis Pharma A/S in a report issued on Wednesday, February 12th. Leerink Partnrs analyst J. Schwartz now expects that the biotechnology company will earn ($1.63) per share for the quarter, […]
Ascendis Pharma A/S (NASDAQ:ASND – Free Report) – Investment analysts at Leerink Partnrs lifted their Q1 2025 earnings per share (EPS) estimates for shares of Ascendis Pharma A/S in a report issued on Wednesday, February 12th. Leerink Partnrs analyst J. Schwartz now expects that the biotechnology company will earn ($1.63) per share for the quarter, […]
